Abstract
Dipyridamole thallium imaging has been proven to be a useful noninvasive test for the evaluation of patients with suspected coronary artery disease. In this report, we discuss the mechanism of dipyridamole's effect on coronary flow, review protocols for performing the test, and discuss the effects of dipyridamole on vital signs, the electrocardiogram, and patients' symptoms. Furthermore, we summarize the present understanding of the indications, sensitivity, specificity, and limitations of this modality.
| Original language | English |
|---|---|
| Pages (from-to) | 292-303 |
| Number of pages | 12 |
| Journal | American Journal of Cardiac Imaging |
| Volume | 2 |
| Issue number | 4 |
| State | Published - 1988 |
| Externally published | Yes |